Growth Metrics

iRhythm Holdings (IRTC) Preferred Stock Liabilities (2015 - 2016)

iRhythm Holdings (IRTC) reported Preferred Stock Liabilities of $3.9 million for Q3 2016, down 95.94% on a QoQ basis from $97.1 million in Q4 2015.

iRhythm Holdings (IRTC) has 2 years of Preferred Stock Liabilities data on file, last reported at $3.9 million in Q3 2016.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $3.9 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $3.9 million (changed N/A YoY) and the FY2015 annual result came in at $97.1 million, up 14.21% from the prior year.
  • Preferred Stock Liabilities declined to $3.9 million in Q3 2016 per IRTC's latest filing, from $97.1 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $97.1 million in Q4 2015 and bottomed at $3.9 million in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 iRhythm Holdings 3.55 Bn 3.00 Bn 141.35 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 3.95 Mn
Dec 31, 2015 97.10 Mn